FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

PAS Expedited Review MAPP Out

CDER issues a Manual of Policies and Procedures specifying how and when the Office of Pharmaceutical Quality will grant or deny a request for an exped...

Human Drugs

Celebrex as Safe as Aleve and Motrin: Advisors

FDA advisors say that a post-marketing study shows that Pfizers Celebrex has cardiac safety risks that are comparable to prescription ibuprofen and na...

Federal Register

Guide on Unapproved New Animal Drug Index

Federal Register notice: FDA makes available a guidance entitled The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species.

Federal Register

Guide on Multi Function Device Products

Federal Register notice: FDA makes available a draft guidance entitled Multiple Function Device Products: Policy and Considerations.

Federal Register

Guide on Clinical Trial Imaging Standards

Federal Register notice: FDA makes available a guidance entitled Clinical Trial Imaging Endpoint Process Standards.

Human Drugs

FDA Launches Digital Health Incubator

FDA commissioner Scott Gottlieb says the agencys new internal data science incubator is one of many steps being taken to implement its digital innovat...

Human Drugs

Approvals of Drugs with Nanomaterials Up

CDER Office of Testing and Research senior staff fellow Xiaoming Xu outlines steps being taken to advance nanotechnology in drug development, along wi...

FDA General

Gottliebs Goodwill on Hill Called Incalculable

FDA commissioner Scott Gottlieb is pleasing everyone on Capitol Hill, reports Alliance for a Stronger FDA deputy executive Steven Grossman in an analy...

Human Drugs

CGMP Violations at Phase 4 Pharmaceutical

FDA warns Phase 4 Pharmaceutical about CGMP violations in its repackaging of OTC transdermal patch products.

Human Drugs

Imaging Endpoint Process Standard Guidance

FDA issues a guidance to assist sponsors to optimize the quality of imaging data from clinical trials used to support approval of drugs and biologics.